Scarica l'app Stockscreener
23.81
0.00%
0.00
Precedente Chiudi:
$0.00
Aprire:
$19.31
Volume 24 ore:
2.94M
Relative Volume:
1.00
Capitalizzazione di mercato:
$1.13B
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$19.31
$25.00
Portata 52W:
$19.31
$25.00
Iambic Therapeutics, Inc. Common Stock Stock (IAM) Company Profile
Nome
Iambic Therapeutics, Inc. Common Stock
Settore
Industria
Telefono
-
Indirizzo
-
Compare IAM vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IAM
Iambic Therapeutics, Inc. Common Stock
|
23.81 | 1.13B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Iambic Therapeutics, Inc. Common Stock Borsa (IAM) Ultime notizie
Iambic Therapeutics CFO Michael Secora Granted RSUs and Stock Options on October 14, 2026 - Kalkine Media
Form 4 Iambic Therapeutics: Michael Secora (CFO & Chief Corp Dev Ofcr) For: 14 October - Investing.com India
Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering - Wilson Sonsini
Total common shares outstanding of Iambic Therapeutics, Inc. – BOATS:IAM - TradingView
IAM SEC FilingsIambic Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Rachlin Evan Lockwood Reports Initial Indirect Ownership in Iambic Therapeutics via Ascenta Capital - Kalkine Media
Iambic Therapeutics prices IPO at $16 per share to raise $150 million - scanx.trade
Iambic Therapeutics prices IPO at $16 per share - Investing.com
Articles from Iambic Therapeutics, Inc. - FinancialContent
Iambic Announces Pricing of Initial Public Offering - Business Wire
Iambic Therapeutics, Inc. has completed an IPO in the amount of $150 million. - www.marketscreener.com
Iambic Therapeutics Files to List Common Stock on Nasdaq Exchange - Kalkine Media
Diluted net income available to common stockholders of IAMBIC THERAPEUTICS INC – NASDAQ:IAM - TradingView
IAMBIC THERAPEUTICS INC Statistics – NASDAQ:IAM - TradingView
NVIDIA-Backed Iambic Therapeutics Files for IPO - Digital Health News
Iambic Therapeutics, Inc. has filed an IPO in the amount of $100 million. - www.marketscreener.com
Iambic Therapeutics, Inc. Common Stock Azioni (IAM) Dati Finanziari
Non sono disponibili dati finanziari per Iambic Therapeutics, Inc. Common Stock (IAM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
6.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):